Articles

Articles and analyses from the INET community on the key economic questions of our time.

Article

Trump, Tariffs, and Exchange Rates: The Message of Elections in the US and Japan

Dec 2, 2024

What Japan, the US, and Europe have in common is growing popular anger over the economy despite high stock prices and low unemployment.

Article

The Deutschmark’s Real Father? A Jewish American Written Out of History.

Oct 10, 2024

In a fresh release from INET’s book series with Cambridge University Press, renowned German economic historian Carl-Ludwig Holtfrerich uncovers the startling truth behind German currency reform usually hailed as the foundation of the post-war German economic miracle: Ludwig Erhard, who cooperated with the Nazis, unjustly claimed the spotlight, overshadowing the real architect, Edward Tenenbaum.

Article

The Fed and the “Soft Landing” - Policy or Luck?

Sep 30, 2024

The biggest factor in accounting for the strength in the economy is the continuing importance of the wealth effect in sustaining consumption by the affluent.

Article

Expert: Why Covid and Future Pandemics are a Bigger Threat than Nukes

Jul 18, 2024

Dr. Phillip Alvelda tells INET’s Lynn Parramore about persistent political and public health failures exposing us to devastating diseases, while vastly underestimating their long-term health effects.

Article

Antitrust Policy and Artificial Intelligence: Some Neglected Issues

Jun 10, 2024

An ensemble of mechanisms enables cloud hegemons (Microsoft, Google, Amazon) to plan the whole AI knowledge and innovation network by weaponizing interdependence in networks.

Article

From Long COVID Odds to Lost IQ Points: Ongoing Threats You Don’t Know About

May 31, 2024

Stuck in a fog of misleading narratives, most of us don’t see the true extent of COVID’s persisting—and intensifying—threats. INET’s Lynn Parramore talks to Dr. Phillip Alvelda about the dangers we’re missing and the failures of public health agencies to inform and protect us. *This is Part 1 of a two-part interview.

Article

The Global Pharmaceutical Industry Isn’t Investing in Products for the Greatest Burden of Human Disease - Are Non-Profits a Solution?

Mar 29, 2024

Programs for expedited review may be preferentially reducing the development costs for conditions with lesser disease burden, potentially making investments in addressing the most significant disease burdens even less appealing and exacerbating the market failure further.

Article

Occupation, Gender, and Labor Market Volatility

Jan 16, 2024

When working within the same employment spell, female workers, particularly those of color and those working in low-wage service and care jobs, earn significantly less when facing greater volatility than their male counterparts or those working in non-service, non-care occupations.